U.S., May 3 -- ClinicalTrials.gov registry received information related to the study (NCT06955390) titled 'Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors' on April 20.
Brief Summary: The purpose of this study is to observe and evaluate the efficacy and safety of HRS-4642 combined with SHR-A2102 in the treatment of advanced solid tumors
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Solid Tumors
Intervention:
DRUG: SHR-A2102+HRS-4642
A fixed dose was used for SHR-A2102,HRS-4642 can be dose adjusted.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Henan Cancer Hospital
Disclaimer: Curated by HT Syndication....